Although the functions of most S100 proteins are still poorly characterized, recent studies indicate that some have pleiotropic pathological functions in NAFLD/NASH fostering progression of these metabolic disorders toward severe stages and cancer development. Here, S100B is linked to metabolic dysfunction-associated steatohepatitis.